LENALIDOMID Accord caps 2.5 mg 21 pce

7680677140013 CH-67714 L04AX04 07.16.4.

Reimbursement limitations:

LENALI.AC.09

LENALIDOMID ACCORD en association avec l’ixazomib et la dexaméthasone
Après accord sur la prise en …

LENALIDOMID Accord caps 2.5 mg 21 pce
LENALIDOMID Accord caps 2.5 mg 21 pce
LENALIDOMID Accord caps 2.5 mg 21 pce
1 / 3
google

Details

Product number
6771401
CPT
-
Packaging group
21
Unit
Kapsel(n)
Composition
lenalidomidum 2.5 mg, lactosum 35.96 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.014 mg, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: E 172 (nigrum), E 171, gelatina, aqua, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, E 171, E 172 (flavum), E 132, pro capsula.

Articles (1)

Lenalidomid Accord 2.5 mg, Hartkapseln
Kapseln
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/01/2023
Patient information leaflet
Français
06/01/2023
Patient information leaflet
Italien
06/01/2023
Professional SmPC
Allemand
06/01/2023
Professional SmPC
Français
06/01/2023
Professional SmPC
Italien
06/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
35.96 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.014 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 766.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2022

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67714
Drug name
Lenalidomid Accord, Hartkapseln
Galenic form
KAHA
ATC Code
L04AX04
Authorization status
Z
Dispensation category
A
First authorization
15/01/2021
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
LENALIDOMID Accord caps 2.5 mg 21 pce
Description (DE)
LENALIDOMID Accord Kaps 2.5 mg 21 Stk
Market launch
15/01/2021
Narcotic (BTM)
No

Original drug

REVLIMID, Hartkapseln
CHF 2480.50
View original

Other packaging sizes

LENALIDOMID Accord caps 5 mg 21 pce
21 KAP
View
LENALIDOMID Accord caps 7.5 mg 21 pce
21 KAP
View
LENALIDOMID Accord caps 10 mg 21 pce
21 KAP
View
LENALIDOMID Accord caps 15 mg 21 pce
21 KAP
View
LENALIDOMID Accord caps 20 mg 21 pce
21 KAP
View
LENALIDOMID Accord caps 25 mg 21 pce
21 KAP
View